BONESUPPORT (Q3 Initial take): Strong US growth and profitability ahead of expectations - Redeye

BONESUPPORT (Q3 Initial take): Strong US growth and profitability ahead of expectations - Redeye

Redeye shares its initial take on BONESUPPORT's Q3 2026 report. Sales and EBIT came in ahead of both our estimates and consensus, driven by strong CERAMENT G US sales. We view the report positively, as it continues to reinforce the profitable sales growth story. We expect the share to trade upwards 7-10% today.

Länk till analysen i sin helhet: https://www.redeye.se/research/1188255/bonesupport-q3-initial-take-strong-us-growth-and-profitability-ahead-of-expectations?utm_source=finwire&utm_medium=RSS